Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

Roundtable

What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Pharma's Almanac

Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

International Markets

In what international markets do you anticipate significant developments in the near future?

Pharma's Almanac

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

Future of the Industry

What key indicators do you look at to predict the future of this industry?

Pharma's Almanac

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac

Immuno-Oncology

Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma

Agilent Technologies

Acquisition

Agilent Technologies Completes Acquisition of Advanced Analytical Technologies, Inc.

Agilent Technologies

Partnership

Agilent Partners with Science Exchange

Agilent Technologies, Inc

Acquisition

Agilent Acquires Cobalt, a Raman Innovator

Steve Kuehn

Nice Insight